Psoriasis

Published on 05/03/2015 by admin

Filed under Dermatology

Last modified 05/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 4643 times

6

Psoriasis

Key Points

Affects up to 2% of the population.

Chronic disorder in those with a polygenic predisposition combined with triggering factors such as infections (especially streptococcal pharyngitis, but also HIV infection) or medications (e.g. interferon, β-blockers, lithium, or oral CS taper).

Koebner phenomenon – elicitation of psoriatic lesions by traumatizing the skin.

Common sites.

Scalp.

Elbows and knees.

Nails, hands, feet, trunk (intergluteal fold).

Skin lesions.

Most commonly – well-demarcated, erythematous plaques with silvery scale (Fig. 6.1).

Other lesions include sterile pustules, glistening plaques in intertriginous zones.

Histopathologic findings.

Regular acanthosis, confluent parakeratosis with neutrophils, hypogranulosis, dilated blood vessels (see Chapter 1).

Major systemic association is psoriatic arthritis (see Table 6.1), most commonly presenting as asymmetric oligoarthritis of hands/feet; the metabolic syndrome is also common.

Pathogenesis.

Regarded as a T-cell-driven disease involving cytokines, including TNF-α and IL-23 (stimulates Th17 cells).

Genes that have been associated with psoriasis include those encoding caspase recruitment domain family member 14 (CARD14, a regulator of NF-κB signaling) and, for generalized pustular psoriasis, the IL-36 receptor antagonist (a regulator of IL-8 production and IL-1β responses).

Variants